Dataset from A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008191
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy and safety of MEDI-546 compared to
placebo in subjects with chronic, moderately-to-severely active systemic lupus erythematosus
(SLE) with an inadequate response to standard of care treatment for SLE.
创建时间：
2025-08-27
